Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP policies and guidelines news

Show

From To
Statement on Gilead’s Announcement of PrEP Donation

Gilead’s donation is an acknowledgment that there is a huge issue with PrEP access in America, as in many parts of the world. We welcome this indication that the company grasps the gravity of the situation. However, we urgently need a lower price for all. It’s disappointing that even this small step has taken so long.

Published
14 May 2019
From
AVAC
Five Reasons the Gilead Giveaway is a Steaming Pile of Truvada

Gilead is engaged in a brilliantly self-serving marketing ploy and dressing it up like charity.

Published
12 May 2019
From
My Fabulous Disease
Fifty new HIV diagnoses at Dean Street linked to caps on IMPACT study

One of the most sobering posters at BHIVA 2019 was able to directly link recent HIV infections to the NHS block on access to PrEP.

Published
10 May 2019
From
HIV i-Base
Generic PrEP to Arrive in September 2020, but Will Big Savings Follow?

Only one company will sell a version of the HIV prevention pill Truvada. When others go to market, prices will likely drop further.

Published
10 May 2019
From
Poz
Gilead Will Donate Truvada to U.S. for H.I.V. Prevention

Officials at the Department of Health and Human Services said the donation came about “as a result of discussions between the Trump administration and Gilead.” Critics said it would not be enough to end the AIDS epidemic and questioned the company’s motives.

Published
10 May 2019
From
The New York Times
PrEP 2-1-1 offered at Magnet, San Francisco

For the first time in the U.S., PrEP “on-demand” dosing is being offered routinely at the San Francisco AIDS Foundation sexual health clinic Magnet.

Published
08 May 2019
From
BETA blog
How About Letting Nurses Provide PrEP to Patients?

Because it’s so important to make sure that pre-exposure prophylaxis (PrEP) is available to people at risk of acquiring HIV, a team of investigators at the University of Ottawa in Ontario, Canada, has proposed that nurses be on the front lines of providing PrEP. Most current guidelines for PrEP are not written for non-prescribing clinicians such as nurses, even though they may be uniquely positioned to assess patients and recommend PrEP.

Published
03 May 2019
From
Contagion Live
US: Health care providers split on who should prescribe HIV prevention drug

University at Buffalo researchers interviewed a small sample of PrEP-prescribing providers in New York State to conduct a qualitative analysis of their perspectives on the preventive medication. Participants were almost equally split on ideal provider type: 15 chose primary care physicians, while 13 said any health care provider. None of the participants indicated a preference for infectious disease or HIV specialists. That's likely because there are approximately 8,500 infectious disease specialists in the U.S., an insufficient number to treat the 1 million individuals who meet PrEP eligibility guidelines.

Published
01 May 2019
From
Eurekalert Inf Dis
Gilead: Stop Blocking PrEP

Members of ACT UP Dublin gathered outside the High Court in Dublin this morning as Gilead’s legal team arrived for the first day of a trial on the validity of the Supplementary Protection Certificate (SPC) for Truvada. The original patent expired in 2017, but the disputed SPC would extend Gilead’s monopoly on Truvada until 2020 in Ireland.

Published
01 May 2019
From
Act Up Dublin
PrEP vs. Privacy

When you’re a young adult on your parents’ insurance, your health decisions are a family affair. And that’s a problem for HIV prevention.

Published
29 April 2019
From
Slate

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.